Doxycycline or Ofloxacin for Outpatient Chlamydial Pelvic Inflammatory Disease? A Cost-Benefit and Cost-Effectiveness Analysis

Objective: The current Centers for Disease Control and Prevention (CDC) guidelines include 2 drugs, doxycycline and ofloxacin, for treatment of the chlamydial component of outpatient pelvic inflammatory disease (PID). Although ofloxacin costs about $90 more than doxycycline, doxycycline is frequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Michael J., Waugh, Michael S.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364411/
https://www.ncbi.nlm.nih.gov/pubmed/18475415
http://dx.doi.org/10.1155/S106474499500024X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364411/
https://www.ncbi.nlm.nih.gov/pubmed/18475415
http://dx.doi.org/10.1155/S106474499500024X

Ejemplares similares